Yaming Su, Ph.D. - Publications

Affiliations: 
2006 Rutgers University, New Brunswick, New Brunswick, NJ, United States 
Area:
Pharmacology, Oncology

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Su YY, Cui HJ, Li KC. Parameter estimation of varying coefficients structural EV model with time series Acta Mathematica Sinica, English Series. 1-13. DOI: 10.1007/s10114-016-3187-6  0.382
2007 Su Y, Hu P, Lee SH, Sinko PJ. Using novobiocin as a specific inhibitor of breast cancer resistant protein to assess the role of transporter in the absorption and disposition of topotecan. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, SociéTé Canadienne Des Sciences Pharmaceutiques. 10: 519-36. PMID 18261372 DOI: 10.18433/J3Qp4W  0.599
2007 Su Y, Zhang X, Sinko PJ. Exploitation of drug-induced Bcl-2 overexpression for restoring normal apoptosis function: a promising new approach to the treatment of multidrug resistant cancer. Cancer Letters. 253: 115-23. PMID 17349740 DOI: 10.1016/J.Canlet.2007.01.018  0.552
2006 Su Y, Lee SH, Sinko PJ. Inhibition of efflux transporter ABCG2/BCRP does not restore mitoxantrone sensitivity in irinotecan-selected human leukemia CPT-K5 cells: evidence for multifactorial multidrug resistance. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 29: 102-10. PMID 16844360 DOI: 10.1016/J.Ejps.2006.06.001  0.628
2006 Su Y, Sinko PJ. Drug delivery across the blood-brain barrier: why is it difficult? how to measure and improve it? Expert Opinion On Drug Delivery. 3: 419-35. PMID 16640501 DOI: 10.1517/17425247.3.3.419  0.557
2004 Zhang X, Wan L, Pooyan S, Su Y, Gardner CR, Leibowitz MJ, Stein S, Sinko PJ. Quantitative assessment of the cell penetrating properties of RI-Tat-9: evidence for a cell type-specific barrier at the plasma membrane of epithelial cells. Molecular Pharmaceutics. 1: 145-55. PMID 15832511 DOI: 10.1021/Mp034014Y  0.577
2004 Su Y, Zhang X, Sinko PJ. Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells. Molecular Pharmaceutics. 1: 49-56. PMID 15832500 DOI: 10.1021/Mp0340136  0.578
2004 Su Y, Lee SH, Sinko PJ. Practical aspects of transporter model systems: a case study involving SQV. Drug Metabolism Reviews. 36: 377-89. PMID 15237860 DOI: 10.1081/Dmr-120037570  0.617
Show low-probability matches.